These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3532967)

  • 1. Cyclosporin A (CyA) in primary Sjögren's syndrome: a double blind study.
    Drosos AA; Skopouli FN; Costopoulos JS; Papadimitriou CS; Moutsopoulos HM
    Ann Rheum Dis; 1986 Sep; 45(9):732-5. PubMed ID: 3532967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness and safety of using cyclosporin A in the treatment of primary Sjögren's syndrome].
    Drosos AA; Moutsopoulos NM
    Ter Arkh; 1988; 60(4):77-80. PubMed ID: 3293257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin a therapy in patients with primary Sjögren's syndrome: results at one year.
    Drosos AA; Skopouli FN; Galanopoulou VK; Kitridou RC; Moutsopoulos HM
    Scand J Rheumatol Suppl; 1986; 61():246-9. PubMed ID: 3296152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cyclosporin A (CyA) on the immunopathological lesion of the labial minor salivary glands from patients with Sjögren's syndrome.
    Dalavanga YA; Detrick B; Hooks JJ; Drosos AA; Moutsopoulos HM
    Ann Rheum Dis; 1987 Feb; 46(2):89-92. PubMed ID: 3493738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nandrolone decanoate (deca-durabolin) in primary Sjögren's syndrome: a double blind pilot study.
    Drosos AA; van Vliet-Dascalopoulou E; Andonopoulos AP; Galanopoulou V; Skopouli FN; Moutsopoulos HM
    Clin Exp Rheumatol; 1988; 6(1):53-7. PubMed ID: 3396249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sjögren's syndrome in systemic lupus erythematosus.
    Andonopoulos AP; Skopouli FN; Dimou GS; Drosos AA; Moutsopoulos HM
    J Rheumatol; 1990 Feb; 17(2):201-4. PubMed ID: 2319519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment.
    Delli K; Haacke EA; Kroese FG; Pollard RP; Ihrler S; van der Vegt B; Vissink A; Bootsma H; Spijkervet FK
    Ann Rheum Dis; 2016 Nov; 75(11):1933-1938. PubMed ID: 26757748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.
    Khurshudian AV
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of total glucosides of peony in the treatment of primary Sjögren's syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trial.
    Liu X; Li X; Li X; Li Z; Zhao D; Liu S; Zhang M; Zhang F; Zhu P; Chen J; Wei W; Lin B; Zhou Y; Chen J; Pang Y; Zhang L; Sun X; Yu Z; Jia Y; Wang J; Sun W; Chiu F; Pang L; Wang G
    Clin Rheumatol; 2019 Mar; 38(3):657-664. PubMed ID: 30280368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Traditional Chinese medicine compound ShengJinRunZaoYangXue granules for treatment of primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled clinical trial.
    Hu W; Qian X; Guo F; Zhang M; Lyu C; Tao J; Gao Z; Zhou Z
    Chin Med J (Engl); 2014; 127(15):2721-6. PubMed ID: 25146603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome.
    Juarez M; Diaz N; Johnston GI; Nayar S; Payne A; Helmer E; Cain D; Williams P; Devauchelle-Pensec V; Fisher BA; Giacomelli R; Gottenberg JE; Guggino G; Kvarnström M; Mariette X; Ng WF; Rosas J; Sánchez Bursón J; Triolo G; Barone F; Bowman SJ
    Rheumatology (Oxford); 2021 Mar; 60(3):1364-1375. PubMed ID: 32949140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sjögren's syndrome presenting with a minor salivary gland mass.
    Kemker BJ; Dayal VS; DeMay RM
    J Otolaryngol; 1998 Oct; 27(5):298-300. PubMed ID: 9800630
    [No Abstract]   [Full Text] [Related]  

  • 13. Brief Report: Ultrasonographic Assessment of Salivary Gland Response to Rituximab in Primary Sjögren's Syndrome.
    Jousse-Joulin S; Devauchelle-Pensec V; Cornec D; Marhadour T; Bressollette L; Gestin S; Pers JO; Nowak E; Saraux A
    Arthritis Rheumatol; 2015 Jun; 67(6):1623-8. PubMed ID: 25708147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
    Petrone D; Condemi JJ; Fife R; Gluck O; Cohen S; Dalgin P
    Arthritis Rheum; 2002 Mar; 46(3):748-54. PubMed ID: 11920411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular changes in major and lingual minor salivary glands in primary Sjögren's syndrome.
    Takahashi H; Tezuka F; Fujita S; Okabe H
    Anal Cell Pathol; 1995 Dec; 9(4):243-56. PubMed ID: 8616101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamivudine is not effective in primary Sjögren's syndrome.
    Gescuk B; Wu AJ; Whitcher JP; Daniels TE; Lund S; Fye K; Davis JC
    Ann Rheum Dis; 2005 Sep; 64(9):1326-30. PubMed ID: 15708886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune hepatitis in primary Sjogren's syndrome: pathological study of the livers and labial salivary glands in 17 patients with primary Sjogren's syndrome.
    Matsumoto T; Morizane T; Aoki Y; Yamasaki S; Nakajima M; Enomoto N; Kobayashi S; Hashimoto H
    Pathol Int; 2005 Feb; 55(2):70-6. PubMed ID: 15693852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of clinical symptoms and laboratory data as diagnostic criteria for Sjögren's syndrome].
    Skopouli FN; Papaioannou T; Kitsios G; Drosos AA; Psilas C
    Ter Arkh; 1988; 60(4):60-3. PubMed ID: 2455941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients.
    Dougados M; Awada H; Amor B
    Ann Rheum Dis; 1988 Feb; 47(2):127-33. PubMed ID: 3281603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial.
    Meijer JM; Meiners PM; Vissink A; Spijkervet FK; Abdulahad W; Kamminga N; Brouwer E; Kallenberg CG; Bootsma H
    Arthritis Rheum; 2010 Apr; 62(4):960-8. PubMed ID: 20131246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.